Therapeutics News and Research

RSS

New drug may enhance efficacy of chemotherapy in pancreatic cancer

One of the major obstacles in the treatment of pancreatic cancer is the 'defense wall' that is formed around the tumor.

5 Sep 2019

Resuscitation from hemorrhagic shock via transfusion of anaerobically stored RBCs improves outcomes

Transfusion of red blood cells (RBCs) stored anaerobically – in the absence of oxygen – is a promising technique to improve resuscitation from hemorrhagic shock, according to animal studies reported in SHOCK: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, Official Journal of the Shock Society.

4 Sep 2019

Tanner Pharma Group signs a distribution agreement for partner therapeutics’ product

Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Partner Therapeutics, Inc., an integrated biopharmaceutical company.

From Tanner Pharma Group 29 Aug 2019

Researchers receive $2.9 million to develop new low-cost cancer diagnostic platform

Researchers at the University of Notre Dame have received $2.9 million to develop a new diagnostic platform that could diagnose cancer in as little as three hours by using only one or two drops of blood.

28 Aug 2019

Nab-Paclitaxel drug combo reduces risk of breast cancer recurrence

A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, “Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?”

27 Aug 2019

U of T scientists create antibodies with enormous potential for regenerative medicine

Our body makes antibodies to fight infections. But the synthetic versions of these molecules could hold the key to stimulating the body's ability to regenerate.

27 Aug 2019

Discovery of protein that may be key to treating tropical diseases

Neglected tropical diseases form a group of infectious parasitic diseases that affect a large percentage of the world population, mostly in emerging nations. Sleeping sickness affects millions in sub-Saharan Africa and is caused by the protozoan parasite, Trypanosoma brucei, which is transmitted by the tsetse fly.

27 Aug 2019

AR glasses could help improve quality of life for low vision patients

Nearly one in 30 Americans over the age of 40 experience low vision significant visual impairment that can't be corrected with glasses, contact lenses, medication or surgery.

27 Aug 2019

Remodeling unhealthful gut microbiomes with the help of synthetic peptides

You are what you eat - right down to the microbiome living in your gut. Diet can affect which microbes are in the intestinal tract, and research has shown that harmful gut microbiome changes can lead to illnesses such as heart disease, obesity and cancer.

27 Aug 2019

Sending reminders and text instructions increases rate of colonoscopies

Having simple text conversations with patients one week before they are scheduled for a colonoscopy dramatically decreased the "no-show" rates, according to a recent study conducted by Penn Medicine researchers.

26 Aug 2019

Antibiotic use linked to increased odds of developing rheumatoid arthritis

A new study has provided evidence that antibiotic usage is associated with an increased risk of developing rheumatoid arthritis.

26 Aug 2019

Living Cells Can Record and Track Genomic Events with New “Designer Cell” Computer Technology

Published in Molecular Cell, researchers at Massachusetts Institute of Technology (MIT) have developed a new technology that uses DNA to process and store information in living cells.

23 Aug 2019

UC San Diego researchers identify new therapeutic approach to kill cancer cells

Epithelial cancers, such as cancers of the lung and pancreas, use the ανβ3 molecule to gain drug resistance to standard cancer therapies and to become highly metastatic.

22 Aug 2019

UCI study finds link between brain immune cells and Alzheimer's disease development

Scientists from the University of California, Irvine School of Biological Sciences have discovered how to forestall Alzheimer's disease in a laboratory setting, a finding that could one day help in devising targeted drugs that prevent it.

21 Aug 2019

Enable Injections enters into a development agreement with Genentech

Enable Injections, Inc., a company developing and manufacturing investigational wearable infusion devices for combination products, today announced it has entered into a development agreement with Genentech, a member of the Roche Group. The enFuseTM, under development by Enable, will enable patient-administered subcutaneous delivery of high-volume therapeutics.

21 Aug 2019